"Business as usual" for HIV screening after discovery of new strain
This article was originally published in Clinica
Executive Summary
Standard HIV screening will diagnose patients infected with a newly-discovered strain of the virus, but not differentiate this new strain from others, Clinica has learnt. The discovery of this fourth "P" variant of type-1 HIV – the others are known as M, which account for the vast majority of cases, O and N – in a Cameroonian woman hospitalised in Paris, was announced this week by French researchers. A spokesperson for the UK HIV and STI charity, the Terence Higgins Trust, told Clinica that current testing will diagnose infection without specifying the identity of the new strain.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.